The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
暂无分享,去创建一个
C. J. Schmidt | T. Humphreys | S. Sorensen | V. L. Taylor | C. K. Black | G. Fadayel | T. Nieduzak | C. Black | Teresa M. Humphreys